How Can AI Be Incorporated Into the Reimbursement Process?
Artificial intelligence (AI) can play a role in systematic literature reviews but should not replace human involvement, according to an analysis presented at the...
A Look at Key Specialty Pharmaceuticals in the Pipeline
A session at the AMCP 2025 Annual Meeting outlined the rapidly expanding specialty pharmacy industry, offering important information on therapeutics in development and how...
Clinical Trials Show Impact of GLP-1 Agonists for Conditions Other Than Diabetes, Obesity
Glucagon-like peptide (GLP)–1 inhibitors are being studied for the treatment of obesity-related comorbidities such as obstructive sleep apnea (OSA), substance use disorder (SUD), heart...
Improvement in Migraine Treatment, Management Has Impact on Quality of Life
Migraines are a neurobiological disorder that impact patients’ quality of life. New therapies are offering promising improvements in migraine prevention and treatment, and managed...
Pharmacy Closures, Generic Spend, GLP-1 Use, and More Hot Topics in Managed Care
A keynote session at the AMCP 2025 Annual Meeting addressed timely pharmaceutical market trends and predicted how the healthcare industry will be impacted over...